Jie Tian

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Venues

Cancer communications (London, England)

Cancer medicine

Nanjing University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Nanjing University Sep 01 2001 - Jul 10 2004

China

PHD :: Physiology

Publications

Xiaoqiang Wang, Song Zhang, Di Jin, Jiamei Luo, Yumiao Shi, Yiqi Zhang, Lingling Wu, Yanling Song, Diansan Su, Zhiying Pan, Haige Chen, Ming Cao, Chaoyong Yang, Weifeng Yu, Jie Tian
μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial. Cancer communications (London, England) 43 (3) (2023)
Xiaoqiang Wang, Song Zhang, Di Jin, Jiamei Luo, Yumiao Shi, Yiqi Zhang, Lingling Wu, Yanling Song, Diansan Su, Zhiying Pan, Haige Chen, Ming Cao, Chaoyong Yang, Weifeng Yu, Jie Tian
μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial. Cancer communications (London, England) (2023)
Xiaoqiang Wang, Song Zhang, Di Jin, Jiamei Luo, Yumiao Shi, Yiqi Zhang, Lingling Wu, Yanling Song, Diansan Su, Zhiying Pan, Haige Chen, Ming Cao, Chaoyong Yang, Weifeng Yu, Jie Tian
μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial. Cancer communications (London, England) 43 (3) (2023)
Xiaoqiang Wang, Song Zhang, Di Jin, Jiamei Luo, Yumiao Shi, Yiqi Zhang, Lingling Wu, Yanling Song, Diansan Su, Zhiying Pan, Haige Chen, Ming Cao, Chaoyong Yang, Weifeng Yu, Jie Tian
μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial. Cancer communications (London, England) 43 (3) (2023)
Xiaoqiang Wang, Song Zhang, Di Jin, Jiamei Luo, Yumiao Shi, Yiqi Zhang, Lingling Wu, Yanling Song, Diansan Su, Zhiying Pan, Haige Chen, Ming Cao, Chaoyong Yang, Weifeng Yu, Jie Tian
μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial. Cancer communications (London, England) 43 (3) (2023)
Yan Liu, Jiaxin Sun, Tong Wu, Xiaoying Lu, Yueyao Du, Hongwei Duan, Weifeng Yu, Dian-San Su, Jinsong Lu, Jie Tian
Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: A prospective randomized controlled trial. Cancer medicine 8 (18) (2019)

Jie Tian.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jie Tian